Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
Remport
A
A
Transplantation and Surgical Department, Semmelweis University, Budapest, Hungary.
Sasvári
I
I
Toronyi
E
E
Borka
P
P
Lázár
N
N
Járay
J
J
Perner
F
F
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000453:epidemiology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007239:Infections / Q000453:epidemiology; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D007970:Leukopenia / Q000453:epidemiology; D008297:Male; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D009894:Opportunistic Infections / Q000453:epidemiology; D011183:Postoperative Complications / Q000453:epidemiology*; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid